154 related articles for article (PubMed ID: 2989149)
21. Nuclear morphometry of benign and malignant breast lesions.
Skjørten F; Kaaresen R; Jacobsen U; Skaane P; Amlie E
Eur J Surg Oncol; 1991 Aug; 17(4):350-3. PubMed ID: 1874292
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of benign proliferative breast disease.
Bodian CA; Perzin KH; Lattes R; Hoffmann P; Abernathy TG
Cancer; 1993 Jun; 71(12):3896-907. PubMed ID: 8389654
[TBL] [Abstract][Full Text] [Related]
23. [Small focal lesions of the breast: a clinico-morphological analysis].
Serov VV; Kuzin MI; Zolotarevskiĭ VB; Zal'tsman IN; Kulakova AM
Arkh Patol; 1984; 46(9):25-32. PubMed ID: 6095796
[TBL] [Abstract][Full Text] [Related]
24. Expression of A and B tissue isoantigens in benign and malignant lesions of the breast.
Strauchen JA; Bergman SM; Hanson TA
Cancer; 1980 Apr; 45(8):2149-55. PubMed ID: 6245789
[TBL] [Abstract][Full Text] [Related]
25. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.
Sappino AP; Skalli O; Jackson B; Schürch W; Gabbiani G
Int J Cancer; 1988 May; 41(5):707-12. PubMed ID: 2835323
[TBL] [Abstract][Full Text] [Related]
26. Automated image morphometry of lobular breast carcinoma.
Rajesh L; Dey P; Joshi K
Anal Quant Cytol Histol; 2002 Apr; 24(2):81-4. PubMed ID: 12026054
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer.
Schrager CA; Schneider D; Gruener AC; Tsou HC; Peacocke M
Hum Pathol; 1998 Jan; 29(1):47-53. PubMed ID: 9445133
[TBL] [Abstract][Full Text] [Related]
28. Pattern of distribution of intraductal and infiltrating ductal carcinoma: a three-dimensional study using serial coronal giant sections of the breast.
Mai KT; Yazdi HM; Burns BF; Perkins DG
Hum Pathol; 2000 Apr; 31(4):464-74. PubMed ID: 10821494
[TBL] [Abstract][Full Text] [Related]
29. Tenascin expression in elastotic cuffs of invasive ductal carcinoma of the breast.
Melis M; Baiocchini A; Soda G; Bosco D
Pathol Res Pract; 1997; 193(7):479-84. PubMed ID: 9342753
[TBL] [Abstract][Full Text] [Related]
30. A contribution to the natural history of breast cancer. I. Duct obliteration with periductal elastosis in the centre of breast cancers.
Egger H; Dressler W
Arch Gynecol; 1982; 231(3):191-8. PubMed ID: 7125701
[TBL] [Abstract][Full Text] [Related]
31. Needle localization and biopsy in non-palpable lesions of the breast: an eight-year experience.
Laraja RD; Rothenberg RE; Herbert L; Pryce EH
N Y State J Med; 1992 Feb; 92(2):71. PubMed ID: 1314357
[No Abstract] [Full Text] [Related]
32. Pathologic considerations in the high-risk breast patient.
Simmons R; Serafin D; McCarty K
Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
[TBL] [Abstract][Full Text] [Related]
33. Pathological aspects of breast cancer screening.
Elston CW
Aust N Z J Surg; 1988 May; 58(5):355-63. PubMed ID: 2845907
[No Abstract] [Full Text] [Related]
34. [Value of cytology for diagnosis of breast cancer].
Tessmann D; Pommerenke F
Z Arztl Fortbild (Jena); 1990; 84(14):719-21. PubMed ID: 2176017
[No Abstract] [Full Text] [Related]
35. Breast cancer and elastosis.
Lundmark C
Cancer; 1972 Nov; 30(5):1195-201. PubMed ID: 4117254
[No Abstract] [Full Text] [Related]
36. Relation of elastosis to biochemical and immunohistochemical steroid receptor findings, Ki-67 and epidermal growth factor receptor (EGFR) immunostaining in invasive ductal breast cancer.
Remmele W; Dietz M; Schmidt F; Schicketanz KH
Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):319-26. PubMed ID: 8389501
[TBL] [Abstract][Full Text] [Related]
37. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
Cook MG; Rohan TE
J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
Egan MJ; Newman J; Crocker J; Collard M
Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical evidence of vimentin in fibrocystic breast disease and mammary carcinoma].
Alexiev B; Valkov I; Popov A
Zentralbl Pathol; 1992 Sep; 138(4):284-8. PubMed ID: 1329942
[TBL] [Abstract][Full Text] [Related]
40. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
